Improving the regulatory review of drugs and devices: Early scientific advice to manufacturers

Improving the regulatory review of drugs and devices: Early scientific advice to manufacturers This project will result in Health Canada and Health Technology Assessment (HTA) organizations working together. This will allow them to give scientific advice to manufacturers at the same time early in the drug development process. 2020-09-17 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyEarly scientific adviceHealth Canada and Health Technology Assessment. Improving the regulatory review of drugs and devices: Early scientific advice to manufacturersHTML https://www.canada.ca/en/health-canada/corporate/transparency/regulatory-transparency-and-openness/improving-review-drugs-devices/early-scientific-advice-manufacturers.html Improving the regulatory review of drugs and devices: Early scientific advice to manufacturersHTML https://www.canada.ca/fr/sante-canada/organisation/transparence/transparence-ouverture-en-matiere-reglementation/examens-reglementaire-materiel-medical/offre-davis-scientifiques-preliminaires-aux-fabricants.html

This project will result in Health Canada and Health Technology Assessment (HTA) organizations working together. This will allow them to give scientific advice to manufacturers at the same time early in the drug development process.

Data and Resources

Similar records